Dimethyl Fumarate
Back to searchMolecule Structure
Scientific Name
Dimethyl Fumarate
Description of the Drug
Dimethyl fumarate is a medication used to treat patients with the relapsing-remitting form of multiple sclerosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB08908
http://www.drugbank.ca/drugs/DB08908
Brand Name(s)
Tecfidera
Company Owner(s)
Mylan Pharmaceuticals Inc, Lupin Inc, Cipla Ltd, Hetero Labs Ltd Unit Iii, Amneal Eu Ltd, Msn Laboratories Private Ltd, Glenmark Pharmaceuticals Ltd, Twi Pharmaceuticals Inc, Pharmathen Sa, Zydus Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Kelch-like ECH-associated protein 1 | SINGLE PROTEIN | INHIBITOR | CHEMBL2069156 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL41835 | |
PharmGKB | PA166152838 | |
WDI | DIMEFUMAR | |
DrugBank | DB08908 | |
PubChem: Thomson Pharma | 15146755 | |
PubChem | 637568 | |
Mcule | MCULE-4208733984 | |
NMRShiftDB | 74928 | |
LINCS | LSM-45569 | |
Nikkaji | J45.019G | J502.486B |
PDBe | EOU | |
BindingDB | 50504654 | |
DrugCentral | 4757 | |
ChemicalBook | CB4854003 | CB6712800 |
Guide to Pharmacology | 7045 | |
GSRS | 00a0cb5d-d9bd-496f-be14-2edc89bc6e0a | |
rxnorm | TECFIDERA | DIMETHYL FUMARATE |
PubChem: Drugs of the Future | 99431554 | |
ChEBI | 76004 | |
ZINC | ZINC000003843378 |